accolade logo

Report: How employers view the weight-loss medication tsunami

GLP-1s have reshaped obesity treatment and healthcare in 2023. What's next in 2024? Accolade's report unpacks trends, costs, and HR insights to help guide employers toward understanding their role in the care continuum of treating obesity

Report: How employers view the weight-loss medication tsunami

In this resource

In 2023, GLP-1 medications have stormed the healthcare scene as a treatment for obesity. But what does 2024 hold? Our report dives into the shifting attitudes of benefits planners towards these treatments. Discover key insights from HR decision-makers, explore cost implications, and understand the rising demand for trusted information.

Are you prepared to optimize your benefits package for an increasingly health-conscious world? Get ahead with Accolade’s comprehensive employee health trends report.

Please select
Please select

By submitting this form, I agree to receive periodic emails from Accolade related to products and services and can unsubscribe at any time.View Privacy Policy.

Assets you might like


Report: Employees are overwhelmed, delaying care at high rates

HR can help overwhelmed employees get care when it matters most. New health trends report explores causes of stress and offers solutions, including virtual care expansion and enhanced health equity...

Read now

Accolade: Adding value to employers and health plans through Personalized Healthcare

A survey conducted by Savanta shows Accolade services improve the employee’s experience and perception of both their health plan and employer...

Read now
Case study

Transportation company increases member engagement while keeping costs under control

Accolade’s personalized advocacy solution sets itself apart from competition.

Read now

Ready for Personalized Healthcare?

CTA image